✨ Medicines Notices
NEW ZEALAND GAZETTE, No. 65 — 22 JUNE 2017
on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister of Health or Director-General to their distribution as medicines, containing not more than six months’ supply, by a registered pharmacist who has successfully completed the approved training programme
Palbociclib
Schedule 2
Restricted Medicines
Levonorgestrel; in medicines for use as emergency post-coital contraception when in packs containing not more than 1.5 milligrams except when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health
Dated this 19th day of June 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health.
2017-go3129
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Lorrex Liquicaps (General sale)
Loperamide hydrochloride 2mg
Soft gelatin capsule
Nova Pharmaceuticals NZ Limited
Marksans Pharma Limited, Verna, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Lorrex Liquicaps (Pharmacy only)
Loperamide hydrochloride 2mg
Soft gelatin capsule
Nova Pharmaceuticals NZ Limited
Marksans Pharma Limited, Verna, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Medix Loperamide Liquicaps (General sale)
Loperamide hydrochloride 2mg
Soft gelatin capsule
Nova Pharmaceuticals NZ Limited
Marksans Pharma Limited, Verna, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Medix Loperamide Liquicaps (Pharmacy only)
Loperamide hydrochloride 2mg
Soft gelatin capsule
Nova Pharmaceuticals NZ Limited
Marksans Pharma Limited, Verna, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Nucala
Mepolizumab 144mg
Powder for injection
GlaxoSmithKline (NZ) Limited
GlaxoSmithKline Manufacturing SpA, Parma, Italy
Dated this 19th day of June 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2017-go3130
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
34
Next Page →
✨ LLM interpretation of page content
🏥
Classification of Medicines
(continued from previous page)
🏥 Health & Social Welfare19 June 2017
Medicines, Classification, Oral Contraception, Palbociclib, Restricted Medicines, Levonorgestrel, Emergency Contraception
- CHRIS JAMES, Group Manager, Medsafe, Ministry of Health
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare19 June 2017
Medicines, Distribution, Loperamide, Mepolizumab, Nova Pharmaceuticals, GlaxoSmithKline
- CHRIS JAMES, Group Manager, Medsafe, Ministry of Health
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare19 June 2017
Medicines, Distribution, Section 24(5), Minister of Health
- CHRIS JAMES, Group Manager, Medsafe, Ministry of Health
NZ Gazette 2017, No 65